Mr. Ronald E. Blaylock is an Independent Director at Advantage Solutions, Inc. (California), an Independent Director at Pfizer Inc., an Independent Director at CarMax, Inc., a Founder, Managing Partner at GenNx360 Capital Partners, an Independent Director at W.R. Berkley Corp. and a Member-Overseers Board at The Leonard N Stern School of Business.
He is on the Board of Directors at Advantage Solutions, Inc. (California), Pfizer Inc., syncreon International Group Ulc, CarMax, Inc., W.R. Berkley Corp., Congressional Black Caucus Foundation, Inc., Harbourton Mortgage Investment Corp., Mebane Charitable Foundation, Novel Ingredient Services LLC, New York University, Prep for Prep and The Carnegie Hall Corp.
Mr. Blaylock was previously employed as an Independent Director by Urban One, Inc., a Chairman & Chief Executive Officer by Blaylock & Co, Inc., a Principal by Citigroup Global Markets, Inc. (Broker), a Principal by PaineWebber, Inc., a Trustee by The Carnegie Hall Society, Inc., and a Principal by UBS Americas, Inc.
He also served on the board at FHC Delaware, Inc., Conyers Park II Acquisition Corp., Covenant House, syncreon Global Holdings Ltd. and syncreon.US, Inc.
He received his undergraduate degree from Georgetown University and an MBA from The Leonard N Stern School of Business.